Inspire Investing’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$687K Sell
47,107
-22,078
-32% -$213K 0.03% 558
2026
Q1
$513K Buy
69,185
+29,834
+76% +$314K 0.03% 711
2025
Q4
$463K Sell
39,351
-19,866
-34% -$214K 0.04% 723
2025
Q3
$457K Buy
59,217
+6,132
+12% +$43K 0.04% 429
2025
Q2
$388K Buy
53,085
+16,325
+44% +$132K 0.04% 640
2025
Q1
$349K Buy
36,760
+12,617
+52% +$158K 0.04% 351
2024
Q4
$398K Sell
24,143
-3,951
-14% -$61.4K 0.04% 724
2024
Q3
$414K Buy
28,094
+3,006
+12% +$47K 0.04% 428
2024
Q2
$348K Buy
25,088
+2,431
+11% +$34.5K 0.04% 712
2024
Q1
$356K Sell
22,657
-1,506
-6% -$23.3K 0.04% 728
2023
Q4
$391K Sell
24,163
-1,496
-6% -$24.5K 0.04% 426
2023
Q3
$316K Buy
+25,659
New +$382K 0.04% 409
2021
Q1
Sell
-8,748
Closed -$470K 694
2020
Q4
$470K Buy
+8,748
New +$395K 0.1% 190

Other funds holding NEO

Inspire Investing's NEO Position: Q2 2026 in Review

Inspire Investing reduced its NeoGenomics (NEO) stake by 32% in Q2 2026, selling an estimated $213K and leaving 47,107 shares worth $687K. The position accounts for 0.03% of the portfolio, ranked #558.

Inspire Investing first reported a position in NEO in Q4 2020 and has held it in 13 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Inspire Investing held 47,107 shares of NeoGenomics worth $687K as of Q2 2026.
  • Inspire Investing sold 22,078 NeoGenomics shares in Q2 2026, an estimated $213K.
  • NeoGenomics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #558 holding.
  • Inspire Investing first reported a position in NeoGenomics in Q4 2020 and has held it in 13 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.